Avantor’s (AVTR) “Equal Weight” Rating Reaffirmed at Barclays

Barclays reissued their equal weight rating on shares of Avantor (NYSE:AVTR) in a report issued on Thursday, Marketbeat reports. Barclays currently has a $12.00 price target on the stock, down from their prior price target of $15.00.

Other analysts also recently issued reports about the company. Morgan Stanley decreased their price target on Avantor from $15.00 to $12.00 and set an “equal weight” rating for the company in a research report on Monday, August 4th. Evercore ISI decreased their price target on Avantor from $18.00 to $16.00 and set an “outperform” rating for the company in a research report on Monday, August 4th. UBS Group set a $12.00 price target on Avantor in a research report on Thursday. Wells Fargo & Company decreased their price target on Avantor from $19.00 to $16.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Finally, Robert W. Baird raised their target price on Avantor from $15.00 to $17.00 and gave the stock an “outperform” rating in a research report on Friday, October 24th. Five analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $14.42.

Avantor Stock Performance

Shares of AVTR opened at $11.04 on Thursday. The company has a current ratio of 1.49, a quick ratio of 0.67 and a debt-to-equity ratio of 0.65. The company has a market capitalization of $7.53 billion, a price-to-earnings ratio of -84.92, a PEG ratio of 3.81 and a beta of 0.98. The stock has a 50 day moving average of $13.36 and a 200 day moving average of $13.30. Avantor has a 12 month low of $10.82 and a 12 month high of $23.70.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $0.22 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.01). The business had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.65 billion. Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The business’s revenue was down 5.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.26 earnings per share. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. As a group, sell-side analysts forecast that Avantor will post 1.06 earnings per share for the current year.

Insider Activity at Avantor

In other news, CAO Steven W. Eck sold 3,476 shares of the firm’s stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total value of $39,591.64. Following the completion of the transaction, the chief accounting officer directly owned 55,068 shares of the company’s stock, valued at $627,224.52. This trade represents a 5.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.20% of the stock is owned by insiders.

Institutional Investors Weigh In On Avantor

Several hedge funds have recently added to or reduced their stakes in the company. Rise Advisors LLC bought a new position in shares of Avantor during the 1st quarter valued at about $25,000. Northwestern Mutual Wealth Management Co. increased its position in shares of Avantor by 288.4% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company’s stock valued at $28,000 after purchasing an additional 1,263 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Avantor by 119.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after purchasing an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC bought a new position in shares of Avantor during the 2nd quarter valued at about $32,000. Finally, Wealthquest Corp bought a new position in shares of Avantor during the 1st quarter valued at about $34,000. Institutional investors own 95.08% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.